Margin squeeze clouds strong 15% growth
Revenue and client additions are on guidance track, but adjusted EBITDA margin fell 520 basis points to 17%. The profitability inflection management promised for H2 is unproven — and the market has already priced in much worse.
₹59.1 Cr
+15% YoY
₹10.0 Cr
-12.3% YoY
17.0%
-520 bps YoY
₹6.4 Cr
+10.6% YoY
Unicommerce's Q2 reads as a tale of two quarters spliced together. On the headline, it's a solid quarter: ₹59.1 crore in revenue, up 15% year-on-year, exactly on guidance track. Uniware (the core order management business) delivered 17.5% growth with 121 new client additions. Shipway (logistics) crossed ₹100 crore in annualized revenue. The real tension emerges below the line: adjusted EBITDA margin compressed 520 basis points to 17%, from 22.2% in Q2 FY26. PAT grew just 10.6% — substantially behind revenue growth — signaling that the cost base is eating into profit scale.
Where the margin went
The 520 basis point margin drop is not mysterious; management flagged it on the call and disclosed it transparently. The culprit: deliberate H1 investments in product development (DNA AI platform, UniReco, UniCapture), talent, and sales/marketing. On a consolidated basis, adjusted EBITDA fell to ₹10 crore from ₹11.4 crore, even as revenue rose. Importantly, Uniware's EBITDA margin within that segment stayed healthy at 36% (within the 32–40% guidance range), confirming the core business remains profitable and scaling. The compression is weighted to Shipway, which is still loss-making as it builds toward the promised Q3 EBITDA breakeven.
Margin compression is a deliberate investment phase; moderation expected from Q3 onwards.
True on intent. But no specific margin target or timeline given; 'moderation' is aspirational, not committed.
Overstated
Both Uniware and Shipway delivered double-digit growth.
Uniware 17.5% ✓. Shipway 15.7%, below the >20% guidance for Q4+. Q2 shows slowdown, not acceleration.
Partially supported
UniReco and UniCapture reached ₹3 Cr annualized revenue.
Accurate. But represents only 2.5% of Uniware; adoption rates 7–8% and 5–6% respectively. Early-stage ramp.
Supported, but limited scale
International business doubled over two years; now 6% of Uniware.
Verified. International grew from 3% at listing to 6%. Growing faster than domestic base.
Supported
ARPU stable despite mix shift to B2B/quick commerce.
ARPU down ~5% H1 YoY despite strong client additions. Mix shift cited as offset, but declining ARPU is a fact.
Overstated (ARPU declining)
What changed on this call
Profitability timeline crystallized: Management committed to Shipway achieving adjusted EBITDA breakeven in Q3 FY27 and PAT profitability in Q4. This is new and unproven.
New products live: UniReco, UniCapture, and DNA AI platform generating revenue and customers, not in development. ₹3 Cr annualized run rate (2.5% mix).
International expansion narrative firmed: Now 6% of Uniware revenue (doubled from 3% at listing). Management reaffirmed 40–50% aspiration over time.
The market's verdict
The stock price tells a brutal story. Unicommerce trades at ₹80.62 — a 69.5% decline from its all-time high of ₹263.99. The stock sits below all major moving averages (SMA20 ₹81.89, SMA50 ₹83.67, SMA200 ₹91.59), trading at the low end of its 52-week range (₹75.05–₹138.9).
FII have essentially exited (0.15% → 0.02%). DII have trimmed holdings from 6.12% to 2.38%. Recent bulk deals show small institutional buyers stepped in at ₹91–₹94 in August 2026; those positions are now underwater by ₹10–₹14 per share. Promoter holdings remain stable at 36%, suggesting no insider confidence signal. The combination of a 69% drawdown, institutional selling, and near-zero FII presence signals deep market skepticism about execution and profitability trajectory.
Uniware 36% EBITDA margin, within 32–40% guidance; profitable and scaling
Consolidated revenue 15% YoY on guidance; 121 net client additions (vs 103 prior year)
Shipway reached ₹100 Cr annualized; strategically important platform anchor
Operating cash flow up 20.6% YoY to ₹11.6 Cr; ₹104.4 Cr cash (up 65% YoY) funds growth
Adjusted EBITDA margin fell 520 bps to 17%; absolute EBITDA down ₹1.4 Cr YoY
PAT growth 10.6% materially behind revenue growth 15%; profitability not scaling
Shipway growth 15.7% YoY below >20% guidance; deceleration not acceleration visible
Margin moderation from Q3+ stated but not quantified; investment timeline unclear
ARPU down 5% H1 YoY despite client growth; mix shift to B2B/quick commerce is structural headwind
FII exited (0.15% → 0.02%); DII trimmed (6.12% → 2.38%); institutional vote of no confidence
Risks, ranked by impact on a holder
Shipway profitability execution: Q3 EBITDA breakeven and Q4 PAT targets not achieved.
CRITICALManagement crystallized new commitments (Q3 EBITDA, Q4 PAT). If Q3 shows Shipway still loss-making, credibility fractures and the margin recovery narrative collapses. Q3 miss forces re-guidance on H2 assumptions.
Margin expansion guidance (20%+) lacks timeline; investment moderation may extend beyond Q2.
HIGHAdjusted EBITDA margin at 17% is the pain point. Management frames it as temporary but provides no Q3 target. If margin stays at 17%+ into H2, the narrative (investment phase concluding) breaks.
Shipway growth remains below 20% guidance; acceleration doesn't materialize from Q4 onwards.
HIGHQ2 Shipway growth at 15.7% is below >20% guidance for Q4+. If growth stays in 15–17% range, the 5x-over-5-years thesis faces a headwind. Slower growth delays path to profitability.
ARPU erosion (5% H1 YoY) accelerates as B2B/quick commerce mix (45–50%) scales.
MEDIUMARPU decline offsets benefit from strong client adds. If ARPU falls 5–10% annually while client growth stays 15–20%, revenue growth scales but profit per customer shrinks.
New product adoption (UniReco, UniCapture) stalls; 2.5% → 10%+ target over 2–3 years fails.
MEDIUMAt 2.5% mix and 7–8%/5–6% adoption, these are early-stage. If ramp slows, differentiation weakens and TAM expansion thesis is questioned.
1 · Q3 FY27 Shipway EBITDA breakeven (due mid-December 2026)
The credibility test. If Shipway achieves adjusted EBITDA breakeven as promised, the inflection narrative holds and Q4 PAT profitability becomes believable. If Q3 EBITDA is still negative, the timeline slips and the entire story fractures. Watch the absolute EBITDA number and rate of loss moderation.
2 · H2 consolidated adjusted EBITDA margin trajectory
Even if Shipway EBITDA breakeven is achieved, consolidated margin improvement depends on Uniware holding at 36% and Shipway moving from losses toward positive. Watch for: (a) margin improvement from 17% in Q2 toward 18%+ in Q3 and 19%+ in Q4, and (b) management's definition of 'steady state' margin (20%+ or lower?).
3 · Shipway growth acceleration from Q4 (due Jan–Feb 2027)
Q2 Shipway growth was 15.7%, below the 20%+ guidance for Q4+. Q3 will signal whether acceleration is beginning (18%+ sequential) or stalling (stays in 15–16% range). Sub-20% growth contradicts guidance and should trigger re-calibration.
Unicommerce is a company in transition. The growth story is intact (15% consolidated, 17.5% Uniware); the client acquisition engine works; Uniware is profitable and scaling at 36% EBITDA margin. But Q2 revealed a softer side: adjusted EBITDA margin fell 520 bps, PAT growth lagged revenue growth, and the profitability inflection management promised remains unproven.
Management has put specific stakes in the ground: Shipway EBITDA breakeven by Q3 FY27 and PAT profitability by Q4. If those land, the narrative (investment phase concluding, operating leverage kicking in) will have legs and the stock — down 69% from ATH — may re-rate on relief. If they slip, the drawdown will compound.
The market has already priced in severe skepticism. FII nearly exited, DII trimmed, recent institutional buyers are under water. For a holder, the question is not whether the company is a great franchise — it clearly is — but whether management's H2 profitability targets are credible. Q3 earnings will be the answer. Until then, this is a cautious Hold: real growth but unproven execution. The single number to track from here is adjusted EBITDA in Q3 — a path to profitability or a miss would reset the story entirely.
Informational and educational content only. Not investment advice.